This study was undertaken to clarify the effect of enzymes induced by ethanol consumption on the pharmacokinetics of trichloroethylene (TRI, a highly metabolised substance) and 1,1,1-trichloroethane (1,1,1-TRI, a poorly metabolized substance). Rats maintained on a control liquid diet or a liquid diet containing ethanol (2 glday/rat) for not less than three weeks were exposed to either TRI (50, 100, 500, and 1000 ppm) or 1,1,1-TRI (50, 100, and 500 ppm) by inhalation for six hours and the concentration of each compound in the blood and the urinary excretion of metabolites (trichloroethanol and trichloroacetic acid) were measured over several hours. Ethanol, which increased the in vitro metabolism of both compounds about fivefold, enhanced the in vivo metabolism of TRI only at high levels of exposure (marginally at 500 and considerably at 1000 ppm), whereas the metabolism of 1,1,1-TRI was enhanced at all concentrations tested. Moreover, there was a definite difference in the effect of induction of enzymes between the two solvents: the enhanced metabolism of TRI in vivo was shown by a decrease in the blood concentration of TRI as well as by an increase in the urinary excretion of its metabolites, whereas that of 1,1,1-TRI was shown by an increase in the urinary excretion of its metabolites alone. These results suggest that the induction of enzymes differentially affects the pharmacokinetics of TRI and 1,1,1-TRI in human occupational exposure: TRI metabolism may be increased only at concentrations much higher than the current occupational exposure limit (mostly 50 ppm), whereas 1,1,1-TRI metabolism may be increased at an exposure similar to occupational exposure. (Occup Environ Med 1994:51:113-119) Hepatic metabolism of organic solvents plays a decisive part in determining the disappearance rate of most organic solvents from the body.' Enzymes that regulate the biotransformation are mono-oxygenases related to cytochrome P-450 and are most concentrated in the liver.2 The metabolic pathway whereby the cytochrome P-450 system is -involved is considered to be the rate limiting step in the overall metabolic processes, because it requires energy to cleave chemical bonds. This enzyme system is susceptible to the influence of various environmental factors including dietary and drinking habits, medication, and exposure to environmental chemicals.3
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Ethanol consumption induces a form of cytochrome P-450 (P-450IIE1),4 which is one of the constitutive microsomal enzymes in both humans5 and other animals.6 It is characterized by its high affinity (low-Km enzyme) for low molecular weight substances, including organic solvents. 7 Experimental evidence has shown that ethanol given to rats accelerates the hepatic metabolism in vitro of a variety of volatile organic solvents including trichloroethylene (TRI) and 1,1,1-trichloroethane (1,1,1-TRI).8 The metabolism enhancing effect of ethanol has also been shown in in vivo metabolism studies.9 10 For example, TRI disappeared faster in ethanol treated, than in control rats when they were exposed to air containing TRI at 500 ppm or higher, and the ethanol treated rats excreted much more trichloroacetic acid (TCA) and trichloroethanol (TCE), the major metabolites of TRI, than did the control rats.'0 These results should be interpreted with caution, however, as occupational exposure to concentrations as high as 500 ppm is unusual.
A simulation study with a physiologically based pharmacokinetic model has shown that the effect of induction of enzymes on the metabolism of inhaled chemicals depends on the chemical as well as on the level of exposure."1 12 The rate of 1,1,1-TRI metabolism is about 1/40 that of TRI metabolism.8 TRI is categorised as a highly metabolised substrate whereas 1,1,1-TRI is poorly metabolised. 12 In our study, we further investigated the working hypothesis that enzyme induction by ethanol consumption may affect the pharmacokinetics of 1,1,1-TRI differently from that of TRI.
Materials and methods

ANIMAL AND DIETS
Eight week old male Wistar rats (Shizuoka Laboratory Animal Centre, Shizuoka) were kept individually in stainless steel wire bottomed metabolism cages in an air conditioned room (22(2)0C) with artificial lighting from 0600 to 1800. They were maintained on unlimited pellet food (Clea CE-2, Nippon Clea, Tokyo) and water. At 10 weeks of age, they were switched to two different liquid diets; one group of rats to a well balanced liquid diet (control diet) and the other group to a diet containing ethanol (ethanol diet).
The control diet was prepared by modifying that described by Lieber and DeCarli."3 Dextrin and maltose were replaced with sucrose and ethyl linoleate was substituted for safflower oil. The control diet (1 kcallml, 80 ml), which constituted food and water for one day, contained 3-31 g casein, 3d17 g oil (corn oil, olive oil, and ethyl linoleate), 9-22 g sucrose, 40 mg L-cystine, 24 mg DL-methionine, 42 mg choline bitartrate, 0-8 g fibre (KC-flock, Sanyo Kokusaku Pulp, Tokyo), 240 mg xanthan gum, 7-2 mg vitamin mixture, and 570 mg mineral mixture. The ethanol diet (1 kcal/ml) was identical to the control diet except that it contained 2-0 g ethanol with a reduction of sucrose content to 3 07 g and an increase of oil content to 4-34 g/80 ml. Thus the ethanol diet was an ethanol containing, low carbohydrate, high fat diet, a prescription that is effective in inducing the ethanol inducible cytochrome P-450."4
After three weeks on the liquid diets, rats were either killed for a metabolism study in vitro or exposed to TRI or 1,1,1-TRI by inhalation for kinetic studies in vivo. On the day of the kinetic studies, all the rats exposed to TRI or 1,1,1-TRI were maintained on the control diet. The experiments were performed in accordance with the guidelines for animal experiments, Medical University of Yamanashi.
METABOUSM OF TRI AND 1,1,I-TRI IN VITRO
Rats were killed by decapitation at 1000 and the liver was removed. A 25% (w/v) liver homogenate in 1-15% KC1 -0-01 M phosphate buffer (pH 7.4) was centrifuged at 10 000 g for 10 minutes. The supernatant was further centrifuged at 105 000 g for 60 minutes to obtain a microsomal pellet that was suspended in the buffer and centrifuged again at 105 000 g for 60 minutes. The washed microsomal pellet was resuspended in the same buffer and the protein content was measured by the method of Lowry et al. '5 The protein content was adjusted to a concentration of 10 mg/ml with the buffer, aerated with N2, and stored frozen at -85°C until use.
Microsomal cytochrome P-450 content was determined spectrophotometrically by the method of Omura and Sato.'6 TRI and 1,1,1-TRI metabolism in vitro was assessed by measuring the rate of substrate (TRI or 1,1,1-TRI) disappearance by the method of Sato and Nakajima"7 with the slight modification that the final volume of reaction mixture was reduced to 0 5 ml consisting of 0 1 ml of microsomal solution (enzyme), 0 3 ml of cofactor solution, and 0-1 ml of substrate solution. The reaction mixture (0 5 ml) contained a final concentration of 1-0 mM NADP, 50 mM MgCl,, 20 mM glucose 6-phosphate (G-6-P), 50 mM K/K phosphate buffer, and 0-11 mM TRI or 010 mM 1,1,1-TRI in addition to two units of G-6-P dehydrogenase and microsomes corresponding to 1-0 mg protein.
EXPOSURE TO TRI AND 1,1,1-TRI BY INHALATION Both control and ethanol treated rats were exposed to air containing TRI at a concentration of 50, 100, 500, or 1000 ppm, or 1,1,1-TRI at a concentration of 50, 100, or 500 ppm for six hours from 1000 to 1600. The exposure was in a dynamic flow exposure chamber as described previously.'8 At preselected intervals after the end of exposure, a small amount of blood (20 pl) was taken from a cut in the tail, and TRI or 1,1,1-TRI concentration in the blood was measured by means of a gas chromatographic syringe equilibration method.'9 The operating conditions of the gas chromatograph were: 2 m x 3 mm glass column packed with PEG-400 on Uniport B (Gasukuro Kogyo, Tokyo) at 80°C; injection port temperature, 1 00°C; carrier gas, N2 at 70 ml/min; H2 at 20 ml/min.
Samples of urine collected at predetermined intervals from the start of exposure for 48 hours were each diluted with distilled water to 100 ml, then centrifuged at 3000 rpm for five minutes. The major urinary metabolites of both TRI and 1,1,1-TRI (TCA and TCE) were analysed in the urine essentially according to the head space gas chromatographic method originally described by Breimer When rats were exposed to TRI at a concentration of 50 or 100 ppm the three week ethanol consumption, which increased the hepatic metabolism of TRI in vitro about five fold, had no influence on the kinetics of TRI: no significant difference was found between control and ethanol treated rats either in the TRI concentration in the blood or in the amounts of TCA and TCE excreted into the urine (figs 1 and 2) . At an exposure level of By contrast, in the case of 1,1,1-TRI, ethanol treated rats excreted more TCA and TCE in the urine than did the control rats at any exposure level studied (figs 5-7). The induction of enzymes however was not reflected in the concentration of 1,1,1-TRI in the blood at any level of exposure. These findings indicate that the effect of induction of enzymes on the pharmacokinetics of 1,1,1 -TRI sharply contrasts with that of TRI. Experimental evidence has been published indicating that induction of enzymes does not always produce a significant effect on the metabolism of inhaled chemicals in a living body. Phenobarbitone is another potent inducer of hepatic cytochrome P-450. Treatment of rats with phenobarbitone accelerated in vivo metabolism of a variety of organic solvents such as m-xylene,2' benzene,26 27 toluene,26 and n-hexane,28 but only at high doses of these solvents.
Phenobarbitone inducible cytochrome P-450 isozymes (primarily, P-45011IB1) have high Km values for organic solvents, by contrast with ethanol inducible P-450IIE1, which is a low Km enzyme for these compounds.629 Our present findings together with the other reports mentioned earlier indicate that enzymes induced by ethanol (a typical inducer of low Km isozymes) or phenobarbitone (a typical inducer of high Km isozymes) will significantly affect the pharmacokinetics of highly metabolised organic solvents only when the exposure concentration is high.
In conclusion, enzyme induction by ethanol consumption may differently affect the pharmacokinetics of TRI and 1,1,1-TRI in human occupational exposure: TRI metabolism may be increased only at an exposure much higher than the current occupational exposure limit (mostly 50 ppm), whereas 1,1,1 -TRI metabolism may be increased at an exposure similar to occupational exposure.
